HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French Experts Call For Mass Vitamin D Supplementation To Fight COVID-19

Executive Summary

With around half the French population vitamin D deficient, a group of medical experts say mass supplementation is a low cost and low risk intervention which could save lives and curb the spread of COVID-19.

You may also be interested in...



Canadian Study Doubts Vitamin D Impact Against COVID-19 As Others Show Protection Correlation

McGill University researchers say multiple analyses of genetic variants study showed no association between genetically predicted vitamin D level and COVID-19 susceptibility, hospitalization or severe disease. CRN’s Vitamin D & Me! campaign reaches 5.6m consumers.

Vitamin D Supplements For Children Present Overdose Risk, Say French Regulators

France's food and drug regulators say children should only be given vitamin D in approved drugs after cases were reported of overdose in infants linked to supplement use.

UK Needs Higher Daily Vitamin D Supplement Doses To Achieve Immunity Effects

Current UK government guidelines on vitamin D supplementation (400IU or 10mcg vitamin D a day) are too low to achieve immunity boosting effects, says UK expert and University of Birmingham scientist Martin Hewison. 

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS150910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel